packageBurosumab

burosumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Burosumab, a monoclonal antibody, is used to treat bone-mineralisation disorders such as familial hypophosphataemia, X-linked hypophosphataemic rickets and osteomalacia. It is an approved medicine, authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q28209068 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:burosumab
ATC codes:M05BX05
DrugBank:DB14012
Wikidata:Q28209068
molar mass:144100 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown